DRD5 and left ventricular hypertrophy: SS‐HPT/Drd5 plasmid complexes were constructed to improve the outcome of left ventricular hypertrophy (Scheme 1), whereas SS‐HPT/Drd5 siRNA served to deteriorate the outcome.